• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA USA, INC. PULSE M102 VNS; STIMULATOR, AUTONOMIC NERVE, IMPLANTED FOR EPILEPSY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA USA, INC. PULSE M102 VNS; STIMULATOR, AUTONOMIC NERVE, IMPLANTED FOR EPILEPSY Back to Search Results
Model Number M102
Device Problem Computer Software Problem (1112)
Patient Problems Incontinence (1928); Nausea (1970); Vertigo (2134); Choking (2464); Sleep Dysfunction (2517); Convulsion/Seizure (4406); Swelling/ Edema (4577)
Event Date 09/29/2022
Event Type  Injury  
Event Description
Implanted medical device programmer was hacked.Symptoms include seizures, swelling, incontinence, nausea, choking, sleep disruption, vertigo, etc.Fda safety report id# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PULSE M102 VNS
Type of Device
STIMULATOR, AUTONOMIC NERVE, IMPLANTED FOR EPILEPSY
Manufacturer (Section D)
LIVANOVA USA, INC.
MDR Report Key15537135
MDR Text Key301189743
Report NumberMW5112400
Device Sequence Number1
Product Code LYJ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 09/29/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberM102
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received10/03/2022
Patient Sequence Number1
Treatment
KEPRA; MULTI-VITAMINS
Patient Outcome(s) Disability; Life Threatening; Hospitalization; Required Intervention;
Patient Age42 YR
Patient SexFemale
Patient Weight71 KG
Patient EthnicityNon Hispanic
Patient RaceBlack Or African American
-
-